Presentation of the product, the C400 IONS, and the service
Normandy Hadrontherapy produces the world’s first compact multi-ion system based on a cyclotron. The C400 IONS, developed by Normandy Hadrontherapy, represents the new generation of multi-ion hadrontherapy.
The technological solution proposed by NHa aims to replace the synchrotron with a cyclotron — a much smaller, significantly less expensive piece of equipment that is easier to operate and maintain. Our solution will also have the advantage of accelerating multiple particles and switching from one particle to another much more easily. This will make hadrontherapy more readily accessible to clinical treatment centres.
This choice is made possible notably thanks to IBA’s expertise in this highly specialised field of particle accelerator development. It should be noted that this same technological leap also enabled proton therapy to develop. Some twenty years ago, IBA took the gamble of developing a cyclotron for proton therapy treatment at a time when centres were mainly using large synchrotrons. It was this innovative choice that enabled, on the one hand, the development of proton therapy treatments, and on the other, IBA to position itself as the global market leader.
